Journal Club - Action of ethanol extract of Bryonia alba on HepG2 liver cancer cells - Ft. Dr. Satadal Das

Written By :  Dr. Nandita Mohan
Written By :  Dr Satadal Das
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-01-25 12:51 GMT   |   Update On 2024-01-25 13:10 GMT

We all know that Alternative medicine comprises well-known ancient Eastern practices such as acupuncture and Tai-chi, as well as herbal medicine, chiropractic manipulation, Reiki, aromatherapy, massage therapy, folk healing, etc. These practices are generally used interchangeably with the term 'alternative medicine,' a designation created in the 19th century to distinguish them as alternatives...

Login or Register to read the full article

We all know that Alternative medicine comprises well-known ancient Eastern practices such as acupuncture and Tai-chi, as well as herbal medicine, chiropractic manipulation, Reiki, aromatherapy, massage therapy, folk healing, etc. These practices are generally used interchangeably with the term 'alternative medicine,' a designation created in the 19th century to distinguish them as alternatives to allopathic medicine.

In this video, we'll talk about the authors who explored Bryonia alba as a new anti-cancer agent against liver cancer cells. Their study, titled 'Action of ultra-diluted ethanol extract of Bryonia alba on HepG2 liver cancer cells', is featured in the Case Reports in Clinical Radiology journal published by Scientific Scholar.

For an in-depth discussion about the research, the Medical Dialogues team engaged with one of the authors, Dr. Satadal Das, from the Department of Tissue Culture Unit at Heritage Institute of Technology in Chowbhaga, Kolkata, India

In this video, Dr. Das answers the following questions:

1. How has your experience as an author writing the engaging article and subsequently getting published in the Case Reports in Clinical Radiology journal?

2. What are the key takeaways for fellow clinicians/researchers in this clinical domain and the generic reader base/patients/students?

3. What shall be the next steps for you and your team in terms of research and clinical implementation?

4. How has been your experience as an author interacting with the editorial team of Scientific Scholar and subsequently being chosen to present your findings to a larger audience via Medical Dialogues?

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News